SCHEMBL23409155

SCHEMBL23409155

CCCCC/C=C\C/C=C\CCCCCCCCP(=O)(OCC)OCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
MEN1 O00255 1/20 0.58
FAAH O00519 1/20 0.58
MAPT P10636 1/20 0.58
PLA2G4A P47712 1/20 0.58
PAFAH1B2 P68402 1/20 0.58
KMT2A Q03164 1/20 0.58
MGLL Q99685 1/20 0.58
ABHD6 Q9BV23 1/20 0.58
LPAR3 Q9UBY5 1/20 0.51
TRPV1 Q8NER1 1/20 0.49
KDM4E B2RXH2 3/20 0.47
F7 P08709 3/20 0.47
F3 P13726 3/20 0.47
PPARG P37231 2/20 0.47
PPARD Q03181 2/20 0.47
PPARA Q07869 2/20 0.47
DUSP3 P51452 1/20 0.47
PTPN7 P35236 1/20 0.47
FFAR1 O14842 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3793665 0.95 LPAR3 (0.56) ALDH1A1MEN1FAAHMAPTPLA2G4A
SCHEMBL30906162 0.89 ALDH1A1 (0.56) ALDH1A1MEN1FAAHMAPTPLA2G4A
SCHEMBL2185289 0.84 PPARD (0.54) FAAHLPAR3PPARDTSHR
SCHEMBL8029516 0.84 PPARD (0.54) FAAHLPAR3PPARDTSHR
SCHEMBL4243149 0.84 PPARD (0.54) FAAHLPAR3PPARDTSHR
SCHEMBL503511 0.84 PPARD (0.54) FAAHLPAR3PPARDTSHR
SCHEMBL11275301 0.84 PPARD (0.54) FAAHLPAR3PPARDTSHR
SCHEMBL2941289 0.84 PPARD (0.54) FAAHLPAR3PPARDTSHR
SCHEMBL11271012 0.84 PPARD (0.54) FAAHLPAR3PPARDTSHR
SCHEMBL503890 0.84 PPARD (0.54) FAAHLPAR3PPARDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11981695-B2 Linoleic acid derivatives, pharmaceutical composition or food composition comprising said linoleic acid derivatives, and their uses Université de Bourgogne (FR) 2024-05-14 US disclosed
US-20210155640-A1 LINOLEIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION COMPRISING SAID LINOLEIC ACID DERIVATIVES, AND THEIR USES EKTAH (FR) 2021-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11981695-B2 Linoleic acid derivatives, pharmaceutical composition or food composition comprising said linoleic acid derivatives, and their uses ALOX15, ALOX12, ALOX15B ALDH1A1 282/4885MEN1 2050/4885FAAH 40/4885
US-20210155640-A1 LINOLEIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION COMPRISING SAID LINOLEIC ACID DERIVATIVES, AND THEIR USES ALOX15, ALOX12, ALOX15B ALDH1A1 282/4885MEN1 2050/4885FAAH 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.